Cargando…
ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database
BACKGROUND: Acquired hemophilia A (AHA) is a rare disorder, and clinical practices for treating AHA have not been fully clarified in Japan. OBJECTIVES: This study aims to investigate the epidemiology of AHA and real-world treatment practices in Japan. PATIENTS/METHODS: This observational study was b...
Autores principales: | Ogawa, Yoshiyuki, Amano, Kagehiro, Matsuo-Tezuka, Yukari, Okada, Norihiro, Murakami, Yoichi, Nakamura, Takao, Yamaguchi-Suita, Haruko, Nogami, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813148/ https://www.ncbi.nlm.nih.gov/pubmed/36331704 http://dx.doi.org/10.1007/s12185-022-03467-w |
Ejemplares similares
-
Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study
por: Nagao, Azusa, et al.
Publicado: (2022) -
Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients’ perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A
por: Shima, Midori, et al.
Publicado: (2020) -
Identification of deep intronic individual variants in patients with hemophilia A by next‐generation sequencing of the whole factor VIII gene
por: Inaba, Hiroshi, et al.
Publicado: (2017) -
Genetic analysis of carrier status in female members of Japanese hemophilia families
por: Shinozawa, Keiko, et al.
Publicado: (2021) -
Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations
por: Yada, Koji, et al.
Publicado: (2019)